AUPQ849900A0 - Injectable composition - Google Patents

Injectable composition

Info

Publication number
AUPQ849900A0
AUPQ849900A0 AUPQ8499A AUPQ849900A AUPQ849900A0 AU PQ849900 A0 AUPQ849900 A0 AU PQ849900A0 AU PQ8499 A AUPQ8499 A AU PQ8499A AU PQ849900 A AUPQ849900 A AU PQ849900A AU PQ849900 A0 AUPQ849900 A0 AU PQ849900A0
Authority
AU
Australia
Prior art keywords
injectable composition
injectable
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPQ8499A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DBL Australia Pty Ltd
Original Assignee
Soltec Research Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Soltec Research Pty Ltd filed Critical Soltec Research Pty Ltd
Priority to AUPQ8499A priority Critical patent/AUPQ849900A0/en
Publication of AUPQ849900A0 publication Critical patent/AUPQ849900A0/en
Priority to AU2001268829A priority patent/AU2001268829A1/en
Priority to PCT/AU2001/000789 priority patent/WO2002002125A1/en
Assigned to DBL AUSTRALIA PTY LTD. reassignment DBL AUSTRALIA PTY LTD. Assignment by Applicant under S 113 Assignors: SOLTEC RESEARCH PTY LTD
Assigned to DBL AUSTRALIA PTY LTD. reassignment DBL AUSTRALIA PTY LTD. Alteration of Name(s) of Applicant(s) under S113 Assignors: SOLTEC RESEARCH PTY LTD
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
AUPQ8499A 2000-06-30 2000-06-30 Injectable composition Abandoned AUPQ849900A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AUPQ8499A AUPQ849900A0 (en) 2000-06-30 2000-06-30 Injectable composition
AU2001268829A AU2001268829A1 (en) 2000-06-30 2001-07-02 Injectable composition
PCT/AU2001/000789 WO2002002125A1 (en) 2000-06-30 2001-07-02 Injectable composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPQ8499A AUPQ849900A0 (en) 2000-06-30 2000-06-30 Injectable composition

Publications (1)

Publication Number Publication Date
AUPQ849900A0 true AUPQ849900A0 (en) 2000-07-27

Family

ID=3822566

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPQ8499A Abandoned AUPQ849900A0 (en) 2000-06-30 2000-06-30 Injectable composition

Country Status (2)

Country Link
AU (1) AUPQ849900A0 (en)
WO (1) WO2002002125A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7361680B2 (en) 1999-07-23 2008-04-22 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
US6545034B1 (en) 1999-07-23 2003-04-08 The Regents Of The University Of California Use of etodolac for the treatment of chronic lymphocytic leukemia
US7129262B2 (en) 1999-07-23 2006-10-31 The Regents Of The University Of California Indole compounds useful for the treatment of cancer
US7105560B1 (en) 1999-07-23 2006-09-12 The Regents Of The University Of California Use of etodolac in the treatment of multiple myeloma
AU2003295336A1 (en) 2002-09-19 2004-04-08 Dennis A. Carson Use of etodoclac to treat hyperplasia
US7199111B2 (en) 2002-12-02 2007-04-03 Bharat Serums & Vaccines Ltd. Aqueous ifosfamide compositions for parenteral administration and a process for their preparations
MXPA05005919A (en) * 2002-12-02 2005-09-21 Bharat Serums & Vaccines Ltd Ifosfamide compositions for parenteral administration and a process for their preparation.
AR072777A1 (en) 2008-03-26 2010-09-22 Cephalon Inc SOLID FORMS OF BENDAMUSTINE CHLORHYDRATE
PL2528602T5 (en) 2010-01-28 2020-09-07 Eagle Pharmaceuticals, Inc. Formulations of bendamustine
PT2827862T (en) 2012-03-20 2024-03-06 Eagle Pharmaceuticals Inc Formulations of bendamustine
JP6516831B2 (en) * 2014-05-09 2019-05-22 オーロメディクス ファーマ エルエルシー Formulation of cyclophosphamide liquid concentrate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3722043A1 (en) * 1986-07-11 1988-01-14 Asta Werke Ag Chem Fab Solutions of oxazaphosphorines with an improved stability, and process for their preparation
US4879286A (en) * 1987-01-28 1989-11-07 Lyphomed, Inc. Cyclophosphamide
EP1023075B1 (en) * 1997-10-13 2006-12-20 Stada Arzneimittel Ag Liquid presentations of oxazaphosphorine-containing pharmaceutical products

Also Published As

Publication number Publication date
WO2002002125A1 (en) 2002-01-10

Similar Documents

Publication Publication Date Title
AU2001286233A1 (en) Cement composition
AU2001282301A1 (en) Fuel composition
HUP0400589A3 (en) Colostrum-based composition
AU2001278755A1 (en) Injections
AUPQ875700A0 (en) Combination compositions
GB0023891D0 (en) Composition
AU2001241098A1 (en) Composition
AUPQ849900A0 (en) Injectable composition
GB0109427D0 (en) Arthropod-controlling composition
AU2001275201A1 (en) Acne-treating composition
AU2001250391A1 (en) Polymeric composition
AU2001287852A1 (en) Composition
AU2002228899A1 (en) Fragrance enhancing compositions with non-polycyclics
AU2001235764A1 (en) Compositions
AU2001287732A1 (en) Copolycarbonate-based composition
GB0007762D0 (en) Composition
AU2001262163A1 (en) Composition
AU5676101A (en) Fuel composition
AUPQ906400A0 (en) Molluscicidal composition
AU2001268829A1 (en) Injectable composition
AU2001265886A1 (en) Compositions
AU2001293931A1 (en) Scorch-delaying composition
GB0119165D0 (en) Composition
AU2001261182A1 (en) Stabilized composition
AUPQ532300A0 (en) Ceramic composition

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: DBL AUSTRALIA PTY LTD.

Free format text: THE FORMER OWNER WAS: SOLTEC RESEARCH PTY LTD.

NAA1 Application designating australia and claiming priority from australian document

Ref document number: 6882901

Country of ref document: AU